|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Carag AG |
|---|---|
| Information provided by: | Carag AG |
| ClinicalTrials.gov Identifier: | NCT00353509 |
Purpose
Prospective mono-center clinical study to evaluate the safety and effectiveness of an intracardiac septal closure device in patients with atrial septum defect (ASD)
| Condition | Intervention |
|---|---|
|
Atrial Septal Defects |
Device: Device Closure of a Septal Defect |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Prospective Mono-Center Clinical Study to Evaluate the Safety and Effectiveness of an Intracardiac Septal Closure Device in Patients With Atrial Septum Defect (ASD) |
Eligibility| Ages Eligible for Study: | 2 Years and older |
| Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Former Serbia and Montenegro | |
| University Childen's Hospital | |
| Belgrade, Former Serbia and Montenegro, 11000 | |
| Principal Investigator: | Ida Jovanovic, Prof. Dr. | University Children's Hospital Belgrade |
More Information
| ClinicalTrials.gov Identifier: | NCT00353509 History of Changes |
| Other Study ID Numbers: | 2006.1621 |
| Study First Received: | July 16, 2006 |
| Last Updated: | October 16, 2007 |
| Health Authority: | Serbia: Agency for Drugs and Medical Substances |
|
Heart Septal Defects Heart Septal Defects, Atrial Heart Defects, Congenital Cardiovascular Abnormalities |
Cardiovascular Diseases Heart Diseases Congenital Abnormalities |